C the Signs Revenue and Competitors
Estimated Revenue & Valuation
- C the Signs's estimated annual revenue is currently $10.4M per year.
- C the Signs's estimated revenue per employee is $280,216
- C the Signs's total funding is $21M.
Employee Data
- C the Signs has 37 Employees.
- C the Signs grew their employee count by 6% last year.
C the Signs's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder and Chief Scientific Officer | Reveal Email/Phone |
2 | Co Founder | Reveal Email/Phone |
3 | Technical Support Engineer | Reveal Email/Phone |
C the Signs Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $10.8M | 50 | -4% | N/A | N/A |
#2 | $42.8M | 144 | 5% | N/A | N/A |
#3 | $10.8M | 50 | -26% | N/A | N/A |
#4 | $54.6M | 184 | 3% | N/A | N/A |
#5 | $62.4M | 210 | 6% | N/A | N/A |
#6 | $27.8M | 103 | 11% | N/A | N/A |
#7 | $6.9M | 32 | -20% | N/A | N/A |
#8 | $268.4M | 710 | 2% | N/A | N/A |
#9 | $102.3M | 303 | 5% | N/A | N/A |
#10 | $15.3M | 63 | -32% | N/A | N/A |
What Is C the Signs?
C the Signs is a cancer prediction system that can identify patients at risk of cancer at the earliest and most curable stage of the disease. \n \nIn under 30 seconds, C the Signs can rapidly identify which cancers a patient is at risk of and recommend the most appropriate test or specialist to diagnose their cancer.\n \nUsing the latest technology, research and evidence, C the Signs enables healthcare providers to give their patients the best chance of surviving cancer.
keywords:N/A
$21M
Total Funding
37
Number of Employees
$10.4M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.2M | 37 | -23% | N/A |
#2 | $7.4M | 37 | 19% | N/A |
#3 | $3.6M | 37 | 9% | N/A |
#4 | $3.5M | 37 | 6% | N/A |
#5 | $3.6M | 37 | -5% | N/A |